Like what you see? Save for your favourites and assessment later on as part of your account Like Everything you see? Save towards your favourites and evaluate later on in the account priceList[psProduct.In July 2016, MDMB-CHMICA was the primary synthetic cannabinoid receptor agonist to get risk-assessed from the EMCDDA (35) and it's lately been sub